VAR2 PHARMACEUTICALS AWARDED THE SIGMAMILLIPORE BIOTECH GRANT 2020

Var2 Pharmaceuticals has been selected as the European winner of the 2020 Advance Biotech Grant Program (SigmaMillipore). VAR2 Pharmaceuticals was chosen for its development of a promising novel pre-clinical cancer drug-conjugate treatment with the potential to treat multiple types of human adult and childhood solid tumors.

 

VAR2 Pharmaceuticals ApS

Ole Maaløes Vej 3
DK-2200 Copenhagen N
CVR: 34621942

T: +45 78 70 19 00